UBS analyst Joshua Chan raised the firm’s price target on Xometry (XMTR) to $55 from $54 and keeps a Neutral rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XMTR:
- Xometry price target lowered to $60 from $70 at Wedbush
- Xometry price target lowered to $55 from $64 at RBC Capital
- Xometry price target lowered to $65 from $75 at Citi
- Buy Rating Maintained on Xometry Amid Strong Momentum, Conservative 2026 Guidance, and Strategically Positive CEO Transition
- William Blair recommends buying Xometry on post-earnings weakness